Trump Nominates Erica Schwartz CDC Director
Analysis based on 35 articles · First reported Apr 16, 2026 · Last updated Apr 18, 2026
The nomination of Erica Schwartz and a new leadership team for the United States — Centers for Disease Control and Prevention (CDC) is expected to bring stability and a renewed focus on public health, potentially restoring market confidence in the agency's scientific integrity. This could positively impact the healthcare industry by providing clearer guidance and reducing uncertainty surrounding health policies, especially regarding vaccines, which have been a point of contention.
President Donald Trump has nominated Erica Schwartz, a former deputy surgeon general, to lead the United States — Centers for Disease Control and Prevention (CDC). This nomination comes after a period of significant turnover and controversy at the agency, with previous nominees Dave Weldon and Susan Monarez failing to secure or maintain the director position. Donald Trump also announced the appointment of Sean Slovenski as Deputy Director and Chief Operating Officer, Jen Shuford as Deputy Director and Chief Medical Officer, and Sara Brenner as Senior Counselor for Public Health to Health Secretary Robert F. Kennedy Jr. The new leadership team aims to restore trust, accountability, and scientific integrity at the CDC. Erica Schwartz's nomination requires United States approval, a process that could take several months. The American Public Health Association has welcomed her nomination, while some, like Aaron Siri, have criticized her past stance on vaccinations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard